Osteopontin facilitates tumor metastasis by regulating epithelial–mesenchymal plasticity

Cell Death and Disease

Volumn 7, Issue 12, 2016, Pages

  Jia, Rongjie ^a,b   Liang, Yingchao ^a,c   Chen, Rui ^a   Liu, Guoke ^a   Wang, Hao ^a   Tang, Min ^a   Zhou, Xuyu ^d   Wang, Huajing ^a   Yang, Yang ^a   Wei, Huafeng ^e   Li, Bohua ^a   Song, Yipeng ^c   Zhao, Jian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b The 305 Hospital of Chinese PLA   (China)

^c YANTAI YUHUANGDING HOSPITAL   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE CELL ADHESION MOLECULE; OSTEOPONTIN; SECRETORY PROTEIN; UVOMORULIN; VASCULOTROPIN; AKT1 PROTEIN, HUMAN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; MICRORNA; MIRN429 MICRORNA, HUMAN; PROTEIN KINASE B; VASCULOTROPIN A;

ADVANCED CANCER; ARTICLE; CANCER GROWTH; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIAL MESENCHYMAL TRANSITION; GOLGI COMPLEX; HCCLM3 CELL LINE; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS; NCI-H1299 CELL LINE; PLEIOTROPY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REGULATORY MECHANISM; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; BAGG ALBINO MOUSE; CELL NUCLEUS; CELL PLASTICITY; DEFICIENCY; GENE EXPRESSION REGULATION; MALE; METABOLISM; NEOPLASM; NUDE MOUSE; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE, TUMOR; CELL NUCLEUS; CELL PLASTICITY; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM METASTASIS; NEOPLASMS; OSTEOPONTIN; PROTO-ONCOGENE PROTEINS C-AKT; TUMOR MICROENVIRONMENT; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 85021938723     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2016.422     Document Type: Article

References (38)

1. Thiery JP. Epithelial–mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442–454.
2. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial–mesenchymal transitions in development and disease. Cell 2009; 139: 871–890.
3. Chaffer CL, Thompson EW, Williams ED. Mesenchymal to epithelial transition in development and disease. Cells Tissues Organs 2007; 185: 7–19.
4. Gunasinghe NP, Wells A, Thompson EW, Hugo HJ. Mesenchymal–epithelial transition (MET) as a mechanism for metastatic colonisation in breast cancer. Cancer Metastasis Rev 2012; 31: 469–478.
5. Korpal M, Ell BJ, Buffa FM, Ibrahim T, Blanco MA, Celia-Terrassa T et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat Med 2011; 17: 1101–1108.
6. Rangaswami H, Bulbule A, Kundu GC. Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol 2006; 16: 79–87.
7. Coppola D, Szabo M, Boulware D, Muraca P, Alsarraj M, Chambers AF et al. Correlation of osteopontin protein expression and pathological stage across a wide variety of tumor histologies. Clin Cancer Res 2004; 10: 184–190.
8. Li NY, Weber CE, Mi Z, Wai PY, Cuevas BD, Kuo PC. Osteopontin up-regulates critical epithelial–mesenchymal transition transcription factors to induce an aggressive breast cancer phenotype. J Am Coll Surg 2013; 217: 17–26.
9. Inoue M, Shinohara ML. Intracellular osteopontin (iOPN) and immunity. Immunol Res 2011; 49: 160–172.
10. Zhao J, Dong L, Liu B, Wu GB, Xu DM, Chen JJ et al. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis. Gastroenterology 2008; 135: 956–968.
11. Zohar R, Lee W, Arora P, Cheifetz S, McCulloch C, Sodek J. Single cell analysis of intracellular osteopontin in osteogenic cultures of fetal rat calvarial cells. J Cell Physiol 1997; 170: 88–100.
12. Zohar R, Suzuki N, Suzuki K, Arora P, Glogauer M, McCulloch CA et al. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J Cell Physiol 2000; 184: 118–130.
13. Zhu B, Suzuki K, Goldberg HA, Rittling SR, Denhardt DT, McCulloch CA et al. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin. J Cell Physiol 2004; 198: 155–167.
14. Junaid A, Moon MC, Harding GE, Zahradka P. Osteopontin localizes to the nucleus of 293 cells and associates with polo-like kinase-1. Am J Physiol Cell Physiol 2007; 292: C919–C926.
15. Shinohara ML, Kim HJ, Kim JH, Garcia VA, Cantor H. Alternative translation of osteopontin generates intracellular and secreted isoforms that mediate distinct biological activities in dendritic cells. Proc Natl Acad Sci USA 2008; 105: 7235–7239.
16. Liu Y, Cao L, Chen R, Zhou X, Fan X, Liang Y et al. Osteopontin promotes hepatic progenitor cell expansion and tumorigenicity via activation of beta-catenin in mice. Stem cells 2015; 33: 3569–3580.
17. Iqbal J, McRae S, Banaudha K, Mai T, Waris G. Mechanism of hepatitis C virus (HCV)-induced osteopontin and its role in epithelial to mesenchymal transition of hepatocytes. J Biol Chem 2013; 288: 36994–37009.
18. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008; 9: 582–589.
19. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, Farshid G et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008; 10: 593–601.
20. Dai J, Peng L, Fan K, Wang H, Wei R, Ji G et al. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells. Oncogene 2009; 28: 3412–3422.
21. Robertson BW, Chellaiah MA. Osteopontin induces beta-catenin signaling through activation of Akt in prostate cancer cells. Exp Cell Res 2010; 316: 1–11.
22. Iliopoulos D, Polytarchou C, Hatziapostolou M, Kottakis F, Maroulakou IG, Struhl K et al. MicroRNAs differentially regulated by Akt isoforms control EMT and stem cell renewal in cancer cells. Sci Signal 2009; 2: ra62.
23. Irie HY, Pearline RV, Grueneberg D, Hsia M, Ravichandran P, Kothari N et al. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 2005; 171: 1023–1034.
24. Long P, Samnakay P, Jenner P, Rose S. A yeast two-hybrid screen reveals that osteopontin associates with MAP1A and MAP1B in addition to other proteins linked to microtubule stability, apoptosis and protein degradation in the human brain. Eur J Neurosci 2012; 36: 2733–2742.
25. Psaila B, Lyden D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer 2009; 9: 285–293.
26. Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med 2013; 19: 1423–1437.
27. Sceneay J, Smyth MJ, Moller A. The pre-metastatic niche: finding common ground. Cancer Metastasis Rev 2013; 32: 449–464.
28. Kang HJ, Lee H, Choi HJ, Youn JH, Shin JS, Ahn YH et al. Non-histone nuclear factor HMGB1 is phosphorylated and secreted in colon cancers. Lab Invest 2009; 89: 948–959.
29. Lu B, Antoine DJ, Kwan K, Lundback P, Wahamaa H, Schierbeck H et al. JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation. Proc Natl Acad Sci USA 2014; 111: 3068–3073.
30. Sakurai Y, Ohgimoto K, Kataoka Y, Yoshida N, Shibuya M. Essential role of Flk-1 (VEGF receptor 2) tyrosine residue 1173 in vasculogenesis in mice. Proc Natl Acad Sci USA 2005; 102: 1076–1081.
31. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling—in control of vascular function. Nat Rev Mol Cell Biol 2006; 7: 359–371.
32. Ha CH, Wang W, Jhun BS, Wong C, Hausser A, Pfizenmaier K et al. Protein kinase D-dependent phosphorylation and nuclear export of histone deacetylase 5 mediates vascular endothelial growth factor-induced gene expression and angiogenesis. J Biol Chem 2008; 283: 14590–14599.
33. Wang S, Li X, Parra M, Verdin E, Bassel-Duby R, Olson EN. Control of endothelial cell proliferation and migration by VEGF signaling to histone deacetylase 7. Proc Natl Acad Sci USA 2008; 105: 7738–7743.
34. Gao D, Joshi N, Choi H, Ryu S, Hahn M, Catena R et al. Myeloid progenitor cells in the premetastatic lung promote metastases by inducing mesenchymal to epithelial transition. Cancer Res 2012; 72: 1384–1394.
35. Park SM, Gaur AB, Lengyel E, Peter ME. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008; 22: 894–907.
36. Chen J, Wang L, Matyunina LV, Hill CG, McDonald JF. Overexpression of miR-429 induces mesenchymal-to-epithelial transition (MET) in metastatic ovarian cancer cells. Gynecol Oncol 2011; 121: 200–205.
37. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007; 129: 1261–1274.
38. Kaplan RN, Riba RD, Zacharoulis S, Bramley AH, Vincent L, Costa C et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005; 438: 820–827.